EMEA-001631-PIP01-14-M03

Key facts

Invented name
Prevymis
Active substance
Letermovir
Therapeutic area
Infectious diseases
Decision number
P/0385/2018
PIP number
EMEA-001631-PIP01-14-M03
Pharmaceutical form(s)
  • Film-coated tablet
  • Granules
  • Concentrate for solution for infusion
Condition(s) / indication(s)
Prevention of cytomegalovirus infection
Route(s) of administration
  • Oral use
  • Intravenous use
Contact for public enquiries
Merck Sharp & Dohme (Europe), Inc. 

Tel. +33 180464738
E-mail: pip.information@merck.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating